Complement factor H is critical in the maintenance of retinal perfusion

American Journal of Pathology

Volumn 175, Issue 1, 2009, Pages 412-421

  Von Leithner, Peter Lundh ^a   Kam, Jaimie Hoh ^a   Bainbridge, James ^a   Catchpole, Ian ^b   Gough, Gerald ^b   Coffey, Peter ^a   Jeffery, Glen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; FLUORESCEIN;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TISSUE PERFUSION; VASCULAR ENDOTHELIUM;

EID: 67649969175     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080927     Document Type: Article

References (34)

1. Wang F, Rendahl KG, Manning WC, Quiroz D, Coyne M, Miller SS: AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. Invest Ophthalmol Vis Sci 2003, 44:781-790
2. Bora PS, Hu Z, Tezel TH, Sohn JH, Kang SG, Cruz JM, Bora NS, Garen A, Kaplan HJ: Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci USA 2003, 100:2679-2684
3. Sepp T, Khan JC, Thurlby DA, Shahid H, Clayton DG, Moore AT, Bird AC, Yates JR: Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 2006, 47:536-540
4. Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ, Ambati J: Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 2006, 103:2328-2333
5. Ebrahem Q, Renganathan K, Sears J, Vasanji A, Gu X, Lu L, Salomon RG, Crabb JW, Anand-Apte B: Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for agerelated macular degeneration. Proc Natl Acad Sci USA 2006, 103: 13480-13484
6. Moore DJ, Hussain AA, Marshall J: Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 1995, 36:1290-1297
7. Spraul CW, Lang GE, Grossniklaus HE: Morphometric analysis of the choroid. Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 1996, 37:2724-2735
8. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL: Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008, 14:194-198
9. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J: Complement factor H polymorphism in agerelated macular degeneration. Science 2005, 308:385-389
10. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005, 102:7227-7232
11. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman GS, Dean M, Allikmets R: Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006, 38:458-462
12. Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y, Bernstein PS, Ge J, Jonasson F, Stefansson E, Helgadottir G, Zabriskie NA, Jonsson T, Bjornsson A, Thorlacius T, Jonsson PV, Thorleifsson G, Kong A, Stefansson H, Zhang K, Stefansson K, Gulcher JR: CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006, 3:e5
13. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT: Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006, 296:301-309
14. Tuo J, Ning B, Bojanowski CM, Lin ZN, Ross RJ, Reed GF, Shen D, Jiao X, Zhou M, Chew EY, Kadlubar FF, Chan, CC: Synergic effect of polymorphisms in ERCC6 5′ flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci USA 2006, 103:9256-9261
15. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson, LV: Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci USA 2006, 103:17456-17461
16. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U: A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006, 38:1173-1177
17. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ, Seddon JM: Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006, 38:1055-1059
18. Francis PJ, Schultz DW, Hamon S, Ott J, Weleber RG, Klein ML: Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS ONE 2007, 2:e1197
19. Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R, McConnell V, Silvestri G, Chakravarthy U: Neovascular age-related macular degeneration risk based on CFH. LOC387715/HTRA1, and smoking. PLoS Med 2007, 4:e355
20. Thurman JM, Holers VM: The central role of the alternative complement pathway in human disease. J Immunol 2006, 176:1305-1310
21. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002, 31:424-428
22. Noris M, Remuzzi G: Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene. PLoS Med 2006, 3:e432
23. Coffey PJ, Gias C, McDermott CJ, Lundh von Leithner P, Pickering MC, Sethi C, Bird A, Fitzke FW, Maass A, Holder GE, Luthert PJ, Salt TE, Moss SE, Greenwood J: Complement factor H-deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci USA 2007, 104:16651-16656
24. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP: VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 2003, 44:2155-2162
25. Schwesinger C, Yee C, Rohan RM, Joussen AM, Fernandez A, Meyer TN, Poulaki V, Ma JJ, Redmond TM, Liu S, Adamis AP, D'Amato RJ: Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001, 158:1161-1172
26. Takemura M, Wakisaka S, Iwase K, Yabuta NH, Nakagawa S, Chen K, Bae YC, Yoshida A, Shigenaga Y: NADPH-diaphorase in the developing rat: lower brainstem and cervical spinal cord, with special reference to the trigemino-solitary complex. J Comp Neurol 1996, 365:511-525
27. Takehana Y, Kurokawa T, Kitamura T, Tsukahara Y, Akahane S, Kitazawa M, Yoshimura N: Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Invest Ophthalmol Vis Sci 1999, 40:459-466
28. Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingemann RO: Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol 2001, 119:861-866
29. Ng EW, Adamis AP: Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005, 40:352-368
30. Schmid-Schonbein GW, Engler RL: Perspectives of leukocyte activation in the microcirculation. Biorheology 1990, 27:859-869
31. Hunigen H, Bisplinghoff P, Plendl J, Bahramsoltani, M: Vascular dynamics in relation to immunolocalisation of VEGF-A, VEGFR-2 and Ang-2 in the bovine corpus luteum. Acta Histochem 2008, 110:462-472
32. Abrera-Abeleda MA, Xu Y, Pickering MC, Smith RJ, Sethi S: Mesangial immune complex glomerulonephritis due to complement factor D deficiency. Kidney Int 2007, 71:1142-1147
33. Mason JC, Lidington EA, Ahmad SR, Haskard DO: bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physiol 2002, 282: C578-C587
34. Zhou J, Jang YP, Kim SR, Sparrow JR: Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci USA 2006, 103:16182-16187